Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Symptoms, Doctors, Treatments, Advances & More

Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Overview

Save information for later
Sign Up

Learn About Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)

What is the definition of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)?
Gastroenteropancreatic neuroendocrine tumor (GEP-NET), also known as carcinoid tumor or islet cell tumor, is a rare disease of cells that control hormones and nerves. Gastroenteropancreatic neuroendocrine tumors most frequently occur in the esophagus, pancreas, stomach, small intestine, colon, rectum, or appendix and can be benign or cancerous. Malignant (cancerous) gastroenteropancreatic neuroendocrine tumors can spread to other parts of the body, such as the lymph nodes, lungs, liver, and bones.
What are the symptoms of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)?
Some individuals with gastroenteropancreatic neuroendocrine tumor may not experience any symptoms. Symptoms of gastroenteropancreatic neuroendocrine tumor may include unexplained weight loss; loss of appetite; nausea; yellowing of the skin, whites of eyes, and mucous membranes (jaundice); facial flushing; and severe diarrhea or gastrointestinal bleeding.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)?
Treatment for a gastroenteropancreatic neuroendocrine tumor that is fast-growing or has spread usually involves surgery to remove the tumor and medications to slow tumor growth, such as octreotide, lanreotide, and telotristat; targeted therapies, such as everolimus and sunitinib; chemotherapy; and peptide receptor radiotherapy (Lu 177 or Lutathera). In individuals with a slow-growing gastroenteropancreatic neuroendocrine tumor, a wait and watch strategy may be followed before deciding on surgery.
Who are the top Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Local Doctors?
Distinguished in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Distinguished in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)

Medical Oncology - Swedish Cancer Institute First Hill

1221 Madison Street, 
Seattle, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Gold is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Gold is Director of Clinical Research and the Program Leader for the Gastrointestinal (GI) Oncology Program at the Swedish Cancer Institute in Seattle, Washington. In 1991, Dr. Gold obtained his degree in medicine with a distinction in research at the University of Miami School of Medicine in Florida. He then completed an internal medicine internship and residency at the University of Washington. Dr. Gold received the Amgen Oncology Fellowship Award while he was training in medical oncology at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. Presently, he is board certified in medical oncology. Dr. Gold’s clinical investigations on GI tumors, and particularly colorectal cancer treatment, can be found in peer-reviewed publications like the Journal of Clinical Oncology, Seminars in Oncology, and Cancer Investigation. Furthermore, he currently serves as a member of the NCI Colon Task Force, and the Southwest Oncology Group, where he serves as the subcommittee co-chair for colon cancer. In his free time, Dr. Gold enjoys photography and spending time with his wife and three sons. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Neuroendocrine Tumor, and Lynch Syndrome. Dr. Gold is board certified in American Board Of Internal Medicine. Dr. Gold is currently accepting new patients.

Elite in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Elite in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)

Moffitt Cancer Center At International Plaza

4101 Jim Walter Blvd, 
Tampa, FL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jonathan Strosberg is an Oncologist practicing medicine in Tampa, Florida. Dr. Strosberg is rated as an Elite provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Liver Embolization, and Pancreaticoduodenectomy. Dr. Strosberg is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Hematology | Oncology
Advanced in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Hematology | Oncology

Aurora Cancer Care

3003 University Dr, 
Marinette, WI 
Languages Spoken:
English, Greek

Emmanouil Alimpertis is a Hematologist and an Oncologist practicing medicine in Marinette, Wisconsin. Dr. Alimpertis is rated as an Advanced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Neuroendocrine Tumor, Familial Prostate Cancer, Prostate Cancer, and Splenectomy. Dr. Alimpertis is board certified in American Board Of Internal Medicine, Hematology.

What are the latest Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started